Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 778 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Kafsack BFC, Pena JDO, Coppens I, Ravindran S, Boothroyd JC, Carruthers VB.  2009.  Rapid membrane disruption by a perforin-like protein facilitates parasite exit from host cells.. Science. 323(5913):530-3.
Kafsack BFC, Llinás M.  2010.  Eating at the table of another: metabolomics of host-parasite interactions.. Cell Host Microbe. 7(2):90-9.
Kaner RJ, Santiago F, Rahaghi F, Michaels E, Moore JP, Crystal RG.  2010.  Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat.. Am J Respir Cell Mol Biol. 43(2):234-42.
Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al..  1999.  Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.
Kang YKenneth, Andjelic S, Binley JM, Crooks ET, Franti M, Iyer SPrasad N, Donovan GP, Dey AK, Zhu P, Roux KH et al..  2009.  Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1.. Vaccine. 27(37):5120-32.
Kang X, Kim H-J, Ramirez M, Salameh S, Ma X.  2010.  The septic shock-associated IL-10 -1082 A > G polymorphism mediates allele-specific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells.. J Immunol. 184(7):3718-24.
Kapitskaya MZ, Dittmer NT, Deitsch KW, Cho WL, Taylor DG, Leff T, Raikhel AS.  1998.  Three isoforms of a hepatocyte nuclear factor-4 transcription factor with tissue- and stage-specific expression in the adult mosquito.. J Biol Chem. 273(45):29801-10.
Kaps I, Ehrt S, Seeber S, Schnappinger D, Martin C, Riley LW, Niederweis M.  2001.  Energy transfer between fluorescent proteins using a co-expression system in Mycobacterium smegmatis.. Gene. 278(1-2):115-24.
Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G.  1998.  Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.. Eur J Immunol. 28(10):3128-36.
Karreci ESula, Fan H, Uehara M, Mihali AB, Singh PK, Kurdi AT, Solhjou Z, Riella LV, Ghobrial I, Laragione T et al..  2016.  Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice.. Proc Natl Acad Sci U S A. 113(52):E8425-E8432.
Kass-Eisler A, Leinwand L, Gall J, Bloom B, Falck-Pedersen E.  1996.  Circumventing the immune response to adenovirus-mediated gene therapy.. Gene Ther. 3(2):154-62.
Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA.  1994.  The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer.. Gene Ther. 1(6):395-402.
Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA, Cipriani L, Leinwand LA.  1993.  Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo.. Proc Natl Acad Sci U S A. 90(24):11498-502.
Kathpalia VP, Mussak EN, Chow SS, Lam PH, Skelley N, Time M, Markelewicz RJ, Kanduc D, Lomas L, Xiang Z et al..  2006.  Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures.. J Dermatol. 33(5):309-18.
Ketas TJ, Holuigue S, Matthews K, Moore JP, Klasse PJohan.  2012.  Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors.. Virology. 422(1):22-36.
Ketas TJ, Schader SM, Zurita J, Teo E, Polonis V, Lu M, Klasse PJohan, Moore JP.  2007.  Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.. Virology. 364(2):431-40.
Kim SJun, Gershov D, Ma X, Brot N, Elkon KB.  2002.  I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation.. J Exp Med. 196(5):655-65.
Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, Hepworth MR, Van Voorhees AS, Comeau MR, Artis D.  2013.  TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation.. Sci Transl Med. 5(170):170ra16.
Kim J-H, Wei J-R, Wallach JB, Robbins RS, Rubin EJ, Schnappinger D.  2011.  Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase.. Nucleic Acids Res. 39(6):2210-20.
Kim S, Elkon KB, Ma X.  2004.  Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells.. Immunity. 21(5):643-53.
Kim SJung, Gershov D, Ma X, Brot N, Elkon KB.  2003.  Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses.. Ann N Y Acad Sci. 987:68-78.
Kim J-H, O'Brien KM, Sharma R, Boshoff HIM, Rehren G, Chakraborty S, Wallach JB, Monteleone M, Wilson DJ, Aldrich CC et al..  2013.  A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence.. Proc Natl Acad Sci U S A. 110(47):19095-100.
Kim H, Zhao Q, Zheng H, Li X, Zhang T, Ma X.  2015.  A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation.. Sci Rep. 5:12018.
Kim S, Chung EY, Ma X.  2005.  Immunological consequences of macrophage-mediated clearance of apoptotic cells.. Cell Cycle. 4(2):231-4.
Kim H-J, Lv D, Zhang Y, Peng T, Ma X.  2012.  Golgi phosphoprotein 2 in physiology and in diseases.. Cell Biosci. 2(1):31.